Stratified cohorts for biomarker assessment and trial readiness: TMEM175 , SCARB2 and CTSB in Parkinson’s disease
Wenhua Sun, Isabel Wurster, Benjamin Röeben, Roswitha Kemmner et autres
0 citationsmedRxiv
Benjamin Röeben
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
73Publications signalées
1479Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsLysosomal Storage Disorders Research
Publications récentes
Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageing
Madeleine Fandrich, Claudia Schulte, Meike Jakobi, Benjamin Röeben et autres
0 citationsParkinsonism & Related Disorders
The PET tracer [ 11 C]MODAG-005 targets alpha-synuclein aggregates in the brain
Ran Sing Saw, Sabrina Haas, Felix Schmidt, Sergey Ryazanov et autres
3 citationsScience Translational Medicine
A molecular biofluid signature of multiple system atrophy (MSA): CSF neurofilament light chain and α-synuclein seeding as complementary biomarkers allow to distinguish MSA from sporadic adult-onset ataxia
Vaibhavi Kadam, Luis Concha-Marambio, Lukas Beichert, Anja Heider et autres
0 citationsmedRxiv
Teaching NeuroImage: Superior Cerebellar Peduncle Tract Sign in SCA27B
Benjamin Röeben, David Pellerin, Benjamin Bender, Matthis Synofzik
1 citationNeurology
Understanding the pattern of cognitive decline in GBA1-related Parkinson’s Disease: a longitudinal multi-cohort study
Merle Bode, Claire Pauly, Sonja R. Jónsdóttir, Claudia Schulte et autres
0 citationsmedRxiv
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson’s disease
Kathrin Brockmann, Alice Ticca, Stefanie Lerche, Andrea Mastrangelo et autres
4 citationsnpj Parkinson s Disease
Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials
Gennaro Pagano, Dylan Trundell, Tanya Simuni, Nicola Pavese et autres
0 citationsnpj Parkinson s Disease
Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab
Kirsten I. Taylor, Florian Lipsmeier, Marzia A. Scelsi, Ekaterina Volkova-Volkmar et autres
14 citationsnpj Digital Medicine
Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseases
Milan Zimmermann, Madeleine Fandrich, Meike Jakobi, Benjamin Röeben et autres
1 citationnpj Parkinson s Disease
Impact of lifestyle factors on quantitative motor and cognitive performance: insights from a longitudinal study on healthy ageing
Milan Zimmermann, Ulrike Suenkel, Isabel Wurster, Stefanie Lerche et autres
3 citationsGeroScience
Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants
Stefanie Lerche, Isabel Wurster, Benjamin Röeben, Milan Zimmermann et autres
3 citationsnpj Parkinson s Disease
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.